Blood proteins may offer new clues to gut health in celiac disease - Medical Xpress

Deji Adekanye, a postdoctoral researcher in the Caplan lab, takes tissue samples from Nicotiana, a tobacco plant found in the Nightshade family. Credit: Kathy F. Atkinson, Caplan Lab Plants—like people—come in all shapes and sizes. And just like scientists want to understand the components of the human body to treat disease and improve our lives, they also want to understand how plants thrive, develop disease, succumb or survive.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.